Claudins in ovarian cancer: emerging biomarkers and therapeutic targets
<p dir="ltr">Tight junctions (TJ) comprise protein complexes that help with the movement of ions and molecules through the paracellular pathway, thus maintaining both epithelial and endothelial integrity. The TJ proteins are diverse and include claudins, occludins, tricellulins, cing...
Saved in:
| Main Author: | Lubna Therachiyil (4246156) (author) |
|---|---|
| Other Authors: | Ajaz A. Bhat (12984701) (author), Shahab Uddin (154400) (author) |
| Published: |
2025
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Claudin-1, A Double-Edged Sword in Cancer
by: Ajaz A. Bhat (12984701)
Published: (2020) -
Fatty acid synthase: A key driver of ovarian cancer metastasis and a promising therapeutic target
by: Nuha Ahmad (22302754)
Published: (2024) -
Deciphering the complex interplay of obesity, epithelial barrier dysfunction, and tight junction remodeling: Unraveling potential therapeutic avenues
by: Sara K. AlMarzooqi (18767743)
Published: (2024) -
The identification of highly upregulated genes in claudin-low breast cancer through an integrative bioinformatics approach
by: Hatem, Zayed
Published: (2020) -
FoxP3<sup>+</sup> T regulatory cells in cancer: Prognostic biomarkers and therapeutic targets
by: Reem Saleh (3513056)
Published: (2020)